MICHELE NOBS: Open Payments
NPI 1386619138 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,889 in 184 payments from 48 companies in 2025. Trend: 2023 $4,316 · 2024 $3,843 · 2025 $3,889
Food & beverage: $3,790Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $300 |
| Daiichi Sankyo Inc. | 11 | $293 |
| Merck Sharp & Dohme LLC | 10 | $242 |
| AstraZeneca Pharmaceuticals LP | 9 | $208 |
| Janssen Biotech, Inc. | 8 | $203 |
| ABBVIE INC. | 11 | $199 |
| EMD Serono, Inc. | 14 | $192 |
| PFIZER INC. | 8 | $155 |
| E.R. Squibb & Sons, L.L.C. | 10 | $155 |
| BeOne Medicines USA, Inc. | 6 | $143 |
Products named: ENHERTU, KEYTRUDA, KISQALI, VENCLEXTA, CARVYKTI, BRUKINSA, Nubeqa, LIBTAYO.
Industry payments across MO — which companies pay providers there.
